FindTrial
Sign In

An electronic nose in the screening for COPD in an at risk population of (ex-)smokers.

An electronic nose as diagnostic tool in the screening for COPD in an at risk population of (ex-)smokers.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20180
Enrollment
250
Registered
2008-04-21
Start date
2008-02-14
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, smoking

Interventions

None: diagnostic study.

Sponsors

Academic Medical Center University of Amsterdam Dept. Pulmonology, F5-260 Meibergdreef 9 1105 AZ Amsterdam The Netherlands University Medical Center Utrecht University of Utrecht Dept. Pulmonology Heidelberglaan 100 3584 CX Utrecht The Netherlands The Nelson Study Group (Nederlands-Leuvens Longkanker Screeningsonderzoek).
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. > 40 years 2. Smoking or ex-smoking 3. > 20 pack years

Exclusion criteria

Exclusion criteria: 1. Failure to complete eNose measurement 2. Not willing to participate in the study or lack of understanding

Design outcomes

Primary

MeasureTime frame
Electronic nose smellprint of a vital capacity volume breath sample.—

Secondary

MeasureTime frame
- Pre- and postbronchodilator spirometry according to ERS/ATS recommendations. - CO diffusion capacity according to ERS/ATS recommendations - Spiral CT scan of the thorax: presence and extent of emphesema - Questionnaires to assess symptoms of COPD, co-morbidity and smoking status.—

Contacts

Public ContactNiki Fens

Clinical Research Fellow 'Electronic Nose' Academic Medical Center (AMC) University of Amsterdam Department of Pulmonology F5-260 P.O.Box 22660

N.Fens@amc.nl+31 (0)20 5664359

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)